a developer of immunotherapy technologies for the treatment of cancer and other diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with KRYS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then KRYS could also see price increases.
Ticker / NAME | Correlation To CLDX | 1D Price Change % | ||
---|---|---|---|---|
CLDX | 100% | -0.63% | ||
KRYS - CLDX | 46% Loosely correlated | -1.60% | ||
SNDX - CLDX | 46% Loosely correlated | +2.59% | ||
ALT - CLDX | 40% Loosely correlated | +0.32% | ||
NTLA - CLDX | 39% Loosely correlated | -3.24% | ||
EDIT - CLDX | 38% Loosely correlated | -3.58% | ||
More |
Ticker / NAME | Correlation To CLDX | 1D Price Change % |
---|---|---|
CLDX | 100% | -0.63% |
cancer theme (82 stocks) | 48% Loosely correlated | -2.38% |
drugs theme (254 stocks) | 41% Loosely correlated | -1.72% |
treatment theme (56 stocks) | 39% Loosely correlated | -1.12% |
immunotherapy theme (12 stocks) | 27% Poorly correlated | -5.83% |
biotechnology theme (238 stocks) | 23% Poorly correlated | -1.80% |